Biological Properties and Therapeutic Applications of Propolis

Phytotherapy Research

Volumn 30, Issue 6, 2016, Pages 894-905

  Sforcin, José M ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

biological properties; propolis; therapeutical applications

Indexed keywords

CHLORHEXIDINE; MOUTHWASH; NANOPARTICLE; PROPOLIS; PLANT RESIN;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CHEMICAL COMPOSITION; DENTAL CARIES; DEPRESSION; DRUG ACTIVITY; DRUG FORMULATION; DRUG MECHANISM; DRUG RESEARCH; GEL; GEOGRAPHY; GINGIVITIS; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MENTAL DISEASE; NONHUMAN; PATENT; REVIEW; STANDARDIZATION; VAGINA CANDIDIASIS; WOUND HEALING; ANIMAL; BEE; CHEMISTRY;

ANIMALS; BEES; PROPOLIS; RESINS, PLANT;

EID: 84960981911     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5605     Document Type: Review

References (169)

1. Almeida RVD, Castro RD, Pereira MSV, Paulo MQ, Santos JP, Padilha WWN,. 2006. Efeito clínico de solução antisséptica a base de própolis em crianças cárie ativas. Pesqui Bras Odontopediatria Clín Integr 6: 87-92.
2. Athikomkulchai S, Awale S, Ruangrungsi N, Ruchirawat S, Kadota S,. 2013. Chemical constituents of Thai propolis. Fitoterapia 88: 96-100.
3. Bachiega TF, Orsatti CL, Pagliarone AC, Sforcin JM,. 2012. The effects of propolis and its isolated compounds on cytokine production by murine macrophages. Phytother Res 26: 1308-1313.
4. Bankova V,. 2005a. Chemical diversity of propolis and the problem of standardization. J Ethnopharmacol 100: 114-117.
5. Bankova V,. 2005b. Recent trends and important developments in propolis research. Evid based Complement Alternat Med 2: 29-32.
6. Bankova V, Popov S, Marekov N, Manolova N, Maksimova V,. 1988. The chemical composition of propolis fractions with antiviral action. Acta Microbiol Bulg 23: 52-57.
7. Bankova V, Christov R, Kujumgiev A, Marcucci MC, Popov S,. 1995. Chemical composition and antibacterial activity of Brazilian propolis. Z Naturforsch C 50: 167-172.
8. Bankova V, Marcucci MC, Simova S, Nikolova N, Kujumgiev A, Popov S,. 1996. Antibacterial diterpenic acids from Brazilian propolis. Z Naturforsch C 51: 277-280.
9. Bankova V, Boudourova-Krasteva G, Popov S, Sforcin JM, Funari SRC,. 1998a. Seasonal variations in essential oil from Brazilian propolis. J Essent Oil Res 10: 693-696.
10. Bankova V, Boudourova-Krasteva G, Popov S, Sforcin JM, Funari SRC,. 1998b. Seasonal variations of the chemical composition of Brazilian propolis. Apidologie 29: 361-367.
11. Bankova V, Boudourova-Krasteva G, Sforcin JM, et al., 1999. Phytochemical evidence for the plant origin of Brazilian propolis from São Paulo State. Z Naturforsch 54c: 401-405.
12. Bankova V, Castro SL, Marcucci MC,. 2000. Propolis: recent advances in chemistry and plant origin. Apidologie 31: 3-15.
13. Bankova V, Popova M, Bogdanov S, Sabatini AG,. 2002. Chemical composition of European propolis: expected and unexpected results. Z Naturforsch C 57: 530-533.
14. Banskota AH, et al., 2000. Cytotoxic, hepatoprotective and free radical scavenging effects of propolis from Brazil, Peru, the Netherlands and China. J Ethnopharmacol 72: 239-246.
15. Banskota AH, Tezuka Y, Kadota S,. 2001. Recent progress in pharmacological research of propolis. Phytother Res 15: 561-571.
16. Barud HS, et al., 2013. Antimicrobial Brazilian propolis (EPP-AF) containing biocellulose membranes as promising biomaterial for skin wound healing. Evid Based Complement Alternat Med 2013: 1-10.
17. Baykara M, Silici S, Özçelik M, Güler O, Erdoǧan N, Bilgen M,. 2015. In vivo nephroprotective efficacy of propolis against contrast-induced nephropathy. Diagn Interv Radiol 21: 317-321.
18. Bazo AP, Rodrigues MAM, Sforcin JM, Camargo JLV, Ribeiro LR, Salvadori DMF,. 2002. Protective action of propolis on the rat colon carcinogenesis. Teratog Carcinog Mutagen 22: 183-194.
19. Beauregard AP, Harquail J, Lassalle-Claux G, et al., 2015. CAPE analogs induce growth arrest and apoptosis in breast cancer cells. Molecules 20: 12576-12589.
20. Berretta AA, Castro PA, Cavalheiro AH, et al., 2013. Evaluation of mucoadhesive gels with propolis (EPP-AF) in preclinical treatment of candidiasis vulvovaginal infection. Evid Based Complement Alternat Med 2013: 1-18.
21. Bhat N, Bapat S, Asawa K, et al., 2015. The antiplaque efficacy of propolis-based herbal toothpaste: a crossover clinical study. J Nat Sci Biol Med 6: 364-368.
22. Boisard S, Le Ray AM, Landreau A, et al., 2015. Antifungal and antibacterial metabolites from a French poplar type propolis. Evid Based Complement Alternat Med 2015: 1-10.
23. Borrelli F, Izzo AA, Di Carlo G, et al., 2002. Effect of a propolis extract and caffeic acid phenethyl ester on formation of aberrant crypt foci and tumors in the rat colon. Fitoterapia 73: S38-43.
24. Boudourova-Krasteva G, Bankova V, Sforcin JM, Nikolova N, Popov S,. 1997. Phenolics from Brazilian propolis. Z Naturforsch 52c: 676-679.
25. Búfalo MC, Sforcin JM,. 2015. The modulatory effects of caffeic acid on human monocytes and its involvement in propolis action. J Pharm Pharmacol 67: 740-745.
26. Búfalo MC, Figueiredo AS, de Sousa JPB, Candeias JMG, Bastos JK, Sforcin JM,. 2009. Anti-poliovirus activity of Baccharis dracunculifolia and propolis by cell viability determination and real-time PCR. J Appl Microbiol 107: 1669-1680.
27. Búfalo MC, Ferreira I, Costa G, et al., 2013. Propolis and its constituent caffeic acid suppress LPS-stimulated pro-inflammatory response by blocking NF-κB and MAPK activation in macrophages. J Ethnopharmacol 149: 84-92.
28. Búfalo MC, Bordon-Graciani AP, Conti BJ, Golim MA, Sforcin JM,. 2014. The immunomodulatory effect of propolis on receptors expression, cytokine production and fungicidal activity of human monocytes. J Pharm Pharmacol 66: 1497-1504.
29. Burdock GA,. 1998. Review of the biological properties and toxicity of bee propolis (propolis). Food ChemToxicol 36: 347-363.
30. Cairo do Amaral R, Gomes RT, Rocha WMS, Abreu SLR, Santos VR,. 2006. Periodontitis treatment with Brazilian green propolis. Pharmacol Online 3: 336-341.
31. Callejo A, Armentia A, Lombardero M, Asensio T,. 2001. Propolis, a new bee-related allergen. Allergy 56: 579.
32. Capoci IRG, Bonfim-Mendonça PS, Arita GS, et al., 2015. Propolis is an efficient fungicide and inhibitor of biofilm production by vaginal Candida albicans. Evid Based Complement Alternat Med 2015: 1-9.
33. de Castro SL,. 2001. Propolis: biological and pharmacological activities. Therapeutic uses of this bee-product. Ann Rev Biomed Sci 3: 49-83.
34. Chan GCF, Cheung KW, Sze DMY,. 2013. The immunomodulatory and anticancer properties of propolis. Clin Rev Allergy Immunol 44: 262-273.
35. Chanyshev ZG, Kudashev AK,. 1976. Chemical composition of propolis. Veterinariia 8: 100.
36. Cho E, Lee JD, Cho SH,. 2011. Systemic contact dermatitis from propolis ingestion. Ann Dermatol 23: 85-88.
37. Christov R, Trusheva B, Popova M, Bankova V, Bertrand M,. 2006. Chemical composition of propolis from Canada, its antiradical activity and plant origin. Nat Prod Res 20: 531-536.
38. Chu WH,. 2006. Adjuvant effect of propolis on immunization by inactivated Aeromonas hydrophila in carp (Carassius auratus gibelio). Fish Shelfish Immunol 21: 113-117.
39. Cigut T, Polak T, Gasperlin L, Raspor P, Jamni P,. 2011. Antioxidative activity of propolis extract in yeast cells. J Agric Food Chem 59: 11449-11455.
40. Cizmárik J, Matel I,. 1970. Examination of the chemical composition of propolis I. Isolation and identification of the 3,4-dihydroxycinnamic acid (caffeic acid) from propolis. Experientia 26: 713.
41. Conti BJ, Búfalo MC, Golim MA, Bankova V, Sforcin JM,. 2013. Cinnamic acid is partially involved in propolis immunomodulatory action on human monocytes. Evid based Complement Alternat Med 2013: 1-7.
42. Conti BJ, Bankova V, Sforcin JM,. 2015a. Chemical composition of the same Brazilian propolis sample analyzed in 1997 and in 2012: no freezing effect. Nat Prod Commun 10: 1279-1280.
43. Conti BJ, Santiago KB, Búfalo MC, et al., 2015b. Modulatory effects of propolis samples from Latin America (Brazil, Cuba and Mexico) on cytokine production by human monocytes. J Pharm Pharmacol 67: 1431-1438.
44. Conti BJ, Santiago KB, Cardoso EO, et al., 2016. Propolis modulates miRNAs involved in TLR-4 pathway, NF-kB activation, cytokine production and in the bactericidal activity of human dendritic cells. Unpublished.
45. Cunha IBS, Sawaya ACHF, Caetano FM, et al., 2004. Factors that influence the yield and composition of Brazilian propolis extracts. J Braz Chem Soc 15: 964-970.
46. Dodwad V, Kukreja BJ,. 2011. Propolis mouthwash: a new beginning. J Indian Soc Periodontol 15: 121-125.
47. Ercan N, Erdemir EO, Ozkan SY, Hendek MK,. 2015. The comparative effect of propolis in two different vehicles; mouthwash and chewing-gum on plaque accumulation and gingival inflammation. Eur J Dent 9: 272-276.
48. Figueiredo SM, Nogueira-Machado JA, Almeida BM, et al., 2014. Immunomodulatory properties of green propolis. Recent Pat Endocr, Metab Immune Drug Discovery 8: 85-94.
49. Fischer G, Conceição FR, Leite FPL, et al., 2007. Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1. Vaccine 25: 1250-1256.
50. Fosquiera EC, Steffens JP, Reinke SMG, et al., 2008. Efeito da própolis no crescimento in vitro de microrganismos associados à periodontite em pacientes HIV-positivos. Periodontia 18: 77-82.
51. Freitas SF, Shinohara L, Sforcin JM, Guimarães S,. 2006. In vitro effects of propolis on Giardia duodenalis trophozoites. Phytomedicine 13: 170-175.
52. Frión-Herrera Y, Díaz-García A, Ruiz-Fuentes J, Rodríguez-Sánchez H, Sforcin JM,. 2015. Brazilian green propolis induced apoptosis in human lung cancer A549 cells through mitochondrial-mediated pathway. J Pharm Pharmacol 67: 1448-1456.
53. Gao W, Wu J, Wei J, et al., 2014. Brazilian green propolis improves immune function in aged mice. J Clin Biochem Nutr 55: 7-10.
54. Gekker G, Hu S, Spivak M, Lokensgard JR, Peterson PK,. 2005. Anti-HIV-1 activity of propolis in CD4(+) lymphocyte and microglial cell cultures. J Ethnopharmacol 102: 158-163.
55. Ghaly MF, Ezzat SM, Sarhan MM,. 1998. Use of propolis and ultragriseofulvin to inhibit aflatoxigenic fungi. Folia Microbiol 43: 156-160.
56. Ghisalberti EL,. 1979. Propolis: a review. Bee World 60: 59-84.
57. Grange JM, Davey RW,. 1990. Antibacterial properties of pro polis (bee glue). J R Soc Med 83: 159-160.
58. Grenho L, Barros J, Ferreira C, et al., 2015. In vitro antimicrobial activity and biocompatibility of propolis containing nanohydroxyapatite. Biomed Mater 10: 1-8.
59. de Groot AC,. 2013. Propolis: a review of properties, applications, chemical composition, contact allergy, and other adverse effects. Dermatitis 24: 263-282.
60. Gulbahar O, Ozturk G, Erdem N, Kazandi AC, Kokuludag A,. 2005. Psoriasiform contact dermatitis due to propolis in a beekeeper. Ann Allergy Asthma Immunol 94: 509-511.
61. Hegazi AG, El Hady FK,. 2001. Egyptian propolis: 1-antimicrobial activity and chemical composition of Upper Egypt propolis. Z Naturforsch C 56: 82-88.
62. Henatsch D, Wesseling F, Kross KW, Stokroos RJ,. 2015. Honey and beehive products in otorhinolaryngology: a narrative review. Clin Otolaryngol. DOI: 10.1111/coa.12557, in press.
63. Hozzein WN, Badr G, Ghamdi AAA, Sayed A, Al-Waili NS, Garraud O,. 2015. Topical application of propolis enhances cutaneous wound healing by promoting TGF-beta/Smad-mediated collagen production in a streptozotocin-induced type I diabetic mouse model. Cell Physiol Biochem 37: 940-954.
64. Huang MT, Ma W, Yen P, et al., 1996. Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells. Carcinogenesis 17: 761-765.
65. Huang S, Zhang CP, Wang K, Li GQ, Hu FL,. 2014. Recent advances in the chemical composition of propolis. Molecules 19: 19610-19632.
66. Huleihel M, Isanu V,. 2002. Anti-herpes simplex virus effect of an aqueous extract of propolis. Isr Med Assoc J 4: 923-927.
67. Isla MI, Zampini IC, Ordóñez RM, et al., 2009. Effect of seasonal variations and collection form on antioxidant activity of propolis from San Juan, Argentina. J Med Food 12: 1334-1342.
68. Ito J, Chang FR, Wang HK, et al., 2001. Anti-AIDS agents. 48.(1) Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis. J Nat Prod 64: 1278-1281.
69. Jacob A, Parolia A, Pau A, Davamani AF,. 2015. The effects of Malaysian propolis and Brazilian red propolis on connective tissue fibroblasts in the wound healing process. BMC Complement Altern Med 2015: 1-10.
70. Janes K, Bumba V,. 1974. Composition of bee glue (propolis). Pharmazie 29: 544-545.
71. Jasprica I, Mornar A, Debeljak Z, et al., 2007. In vivo study of propolis supplementation effects on antioxidative status and red blood cells. J Ethnopharmacol 110: 548-554.
72. Kheiri F, Sabzi RE, Jannatdoust E, Shojaeefar E, Sedghi H,. 2011. A novel amperometric immunosensor based on acetone-extracted propolis for the detection of the HIV-1 p24antigen. Biosens Bioelectron 26: 4457-4463.
73. Kim DM, Lee GD, Aum SH, Kim HJ,. 2008. Preparation of propolis nanofood and application to human cancer. Biol Pharm Bull 31: 1704-1710.
74. Kimoto T, Arai S, Kohguchi M, et al., 1998. Apoptosis and suppression of tumor growth by artepillin C extracted from Brazilian propolis. Cancer Detect Prev 22: 506-515.
75. Krell R,. 1996. Value-added products from beekeeping, FAO Agricultural Services Bulletin 124. Food and Agriculture Organization of the United Nations: Rome. ISBN 92-5-103819-8; 157-184.
76. Król W, Bankova V, Sforcin JM, Szliszka E, Czuba Z, Kuropatnicki AK,. 2013. Propolis: properties, applications, and its potential. Evid Based Complement Altern Med 2013: 1-2.
77. Kubiliene L, Laugaliene V, Pavilonis A, et al., 2015. Alternative preparation of propolis extracts: comparison of their composition and biological activities. BMC Complem Altern Med 15: 156-162.
78. Kucharzewski M, Kubacka S, Urbanek T, Wilemska-Kucharzewska K, Morawiec T,. 2013. Stan Scheller: the forerunner of clinical studies on using propolis for poor and chronic nonhealing wounds. Evid Based Complement Alternat Med 2013: 1-5.
79. Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S,. 1999. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol 64: 235-240.
80. Kuo HC, Kuo WH, Lee YJ, Lin WL, Chou FP, Tseng TH,. 2006. Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo. Cancer Lett 234: 199-208.
81. Lee YJ, Liao PH, Chen WK, Yang CY,. 2000. Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells. Cancer Lett 153: 51-56.
82. Lee YJ, Kuo HC, Chu CH, Wang CJ, Lin WC, Tseng TH,. 2003. Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochem Pharmacol 66: 2281-2289.
83. Lee YT, Don MJ, Hung PS, et al., 2005. Cytotoxic of phenolic acid phenethyl esters on oral cancer cells. Cancer Lett 223: 19-25.
84. Lee MS, Kim YH, Park WS, et al., 2013. Novel antidepressant-like activity of propolis extract mediated by enhanced glucocorticoid receptor function in the hippocampus. Evid Based Complement Alternat Med 2013: 1-10.
85. Liao HF, Chen YY, Liu JJ, et al., 2003. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem 51: 7907-7912.
86. Libério SA, Pereira AL, Araújo MJ, et al., 2009. The potential use of propolis as a cariostatic agent and its action on mutans group streptococci. J Ethnopharmacol 125: 1-9.
87. Liu R, Wu CX, Zhou D, et al., 2012. Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis. BMC Med 10: 105.
88. Mani F, Damasceno HCR, Novelli ELB, Martins EAM, Sforcin JM,. 2006. Propolis: effect of different concentrations, extracts and intake period on seric biochemical variables. J Ethnopharmacol 105: 95-98.
89. Marcucci MC,. 1995. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 26: 83-99.
90. Martinotti S, Ranzato E,. 2015. Propolis: a new frontier for wound healing? Burns Trauma 3: 9-15.
91. Massaro CF, Simpson JB, Powell D, Brooks P,. 2015a. Chemical composition and antimicrobial activity of honeybee (Apis mellifera ligustica) propolis from subtropical eastern Australia. Sci Nat 102: 1-11.
92. Massaro CF, Smyth TJ, Smyth WF, et al., 2015b. Phloroglucinols from anti-microbial deposit-resins of Australian stingless bees (Tetragonula carbonaria). Phytother Res 29: 48-58.
93. Matos D, Serrano P, Brandão FM,. 2014. A case of allergic contact dermatitis caused by propolis-enriched honey. Contact Dermatitis 72: 59-60.
94. Matsui T, Ebuchi S, Fujise T, et al., 2004. Strong antihyperglycemic effects of water-soluble fraction of Brazilian propolis and its bioactive constituent, 3,4,5-tri-O-caffeoylquinic acid. Biol Pharm Bull 27: 1797-1803.
95. Mirzoeva OK, Grishanin RN, Calder PC,. 1997. Antimicrobial action of propolis and its components, the effects on growth membrane potential, and motility of bacteria. Microbiol Res 152: 239-246.
96. Missima F, Pagliarone AC, Orsatti CL, Araújo JP, Sforcin JM,. 2010. The effect of propolis on Th1/Th2 cytokine expression and production by melanoma-bearing mice submitted to stress. Phytother Res 24: 1501-1507.
97. Morawiec T, Mertas A, Wojtyczka RD, et al., 2015. The assessment of oral microflora exposed to 3% ethanolic extract of Brazilian green propolis preparation used for hygiene maintenance following minor oral surgeries. Biomed Res Int 2015: 1-10.
98. Moriyasu J, Arai S, Motoda R, Kurimoto M,. 1994. In vitro activation of mouse macrophage by propolis extract powder. Biotherapy 8: 364-365.
99. Münstedt K, Hellner M, Hackethal A, Winter D, von Georgi R,. 2007. Contact allergy to propolis in beekeepers. Allergol Immunopathol 35: 95-100.
100. Nieva Moreno MI, Isla MI, Cudmani NG, Vattuone MA, Sampietro AR,. 1999. Screening of antibacterial activity of Amaicha del Valle (Tucumán, Argentina) propolis. J Ethnopharmacol 68: 97-102.
101. Olczyk P, Wisowski G, Komosinska-Vassev K, et al., 2013. Propolis modifies collagen types I and III accumulation in the matrix of burnt tissue. Evid Based Complement Alternat Med 2013: 1-10.
102. Orsatti CL, Missima F, Pagliarone AC, et al., 2010. Propolis immunomodulatory action in vivo on Toll-like receptors 2 and 4 expression and on pro-inflammatory cytokines production in mice. Phytother Res 24: 1141-1146.
103. Orsi RO, Funari SRC, Soares AMVC, et al., 2000. Immunomodulatory action of propolis on macrophage activation. J Venom Anim Toxins 6: 205-219.
104. Orsi RO, Sforcin JM, Rall VLM, Funari SRC, Barbosa L, Fernandes A Jr,. 2005. Susceptibility profile of Salmonella against the antibacterial activity of propolis produced in two regions of Brazil. J Venom Anim Toxins 11: 109-116.
105. Orsi RO, Sforcin JM, Funari SRC, Fernandes A Jr, Bankova V,. 2006. Synergistic effect of propolis and antibiotics on the Salmonella Typhi. Braz J Microbiol 37: 108-112.
106. Orsi RO, Fernandes A Jr, Bankova V, Sforcin JM,. 2012a. Antibacterial effects of Brazilian and Bulgarian propolis and synergistic effects with antibiotics acting on the bacterial DNA and folic acid. Nat Prod Res 26: 344-349.
107. Orsi RO, Fernandes A Jr, Bankova V, Sforcin JM,. 2012b. The effects of Brazilian and Bulgarian propolis in vitro against Salmonella Typhi and their synergism with antibiotics acting on the ribosome. Nat Prod Res 26: 430-437.
108. Orsolic N, Basic I,. 2003. Immunomodulation by water-soluble derivative of propolis: a factor of antitumor reactivity. J Ethnopharmacol 84: 265-273.
109. Orsolic N, Knezevic AH, Sver L, Terzic S, Basic I,. 2004. Immunomodulatory and antimetastatic action of propolis and related polyphenolic compounds. J Ethnopharmacol 94: 307-315.
110. Orsolic N, Sver L, Terzic S, Basic I,. 2005. Peroral application of water-soluble derivative of propolis (WSDP) and its related polyphenolic compounds and their influence on immunological and antitumor activity. Vet Res Commun 29: 575-593.
111. Ota C, Unterkircher C, Fantinato V, Shimizu MT,. 2001. Antifungal activity of propolis on different species of Candida. Mycoses 44: 375-378.
112. Papachroni D, Graikou K, Kosalec I, Damianakos H, Ingram V, Chinou I,. 2015. Phytochemical analysis and biological evaluation of selected African propolis samples from Cameroon and Congo. Nat Prod Commun 10: 67-70.
113. Park JH, Lee JK, Kim HS, et al., 2004. Immunomodulatory effect of caffeic acid phenethyl ester in BALB/c mice. Int Immunopharmacol 4: 429-436.
114. Patel S,. 2016. Emerging adjuvant therapy for cancer: propolis and its constituents. J Diet Suppl 13: 245-268, in press.
115. Peng L, Yang S, Cheng YJ, Chen F, Pan S, Fan G,. 2012. Antifungal activity and action mode of pinocembrin from propolis against Penicillium italicum. Food Sci Biotechnol 21: 1533-1539.
116. Pepeljnjak S, Jalsenjak I, Maysinger D,. 1982. Growth inhibition of Bacillus subtilis and composition of various propolis extracts. Pharmazie 37: 864-865.
117. Piana GM, Sforcin, JM,. 2015. Composição odontológica para controle da placa bacteriana. Patent: BR102015003982-4.
118. Pietta PG, Gardana C, Pietta AM,. 2002. Analytical methods for quality control of propolis. Fitoterapia 73: 7-20.
119. Popova M, Bankova V, Spassov S, et al., 2001. New bioactive chalcones in propolis from El Salvador. Z Naturforsch 56: 593-596.
120. Popova M, Silici S, Kaftanoglu O, Bankova V,. 2005. Antibacterial activity of Turkish propolis and its qualitative and quantitative chemical composition. Phytomedicine 12: 221-228.
121. Popova MP, Chinou IB, Marekov IN, Bankova VS,. 2009. Terpenes with antimicrobial activity from Cretan propolis. Phytochemistry 70: 1262-1271.
122. Popova MP, Graikou K, Chinou I, Bankova VS,. 2010. GC-MS profiling of diterpene compounds in Mediterranean propolis from Greece. J Agric Food Chem 58: 3167-3176.
123. Rao CV, Desai D, Rivenson A, Simi B, Amin S, Reddy BS,. 1995. Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate. Cancer Res 55: 2310-2315.
124. Ribeiro DR, Alves AV, Santos EP, et al., 2015. Inhibition of DMBA-induced oral squamous cells carcinoma growth by Brazilian red propolis in rodent model. Basic Clin Pharmacol Toxicol 117: 85-95.
125. Rizk SM, Zaki HF, Mina MA,. 2014. Propolis attenuates doxorubicin-induced testicular toxicity in rats. Food Chem Toxicol 67: 176-186.
126. Rocha BA, Bueno PCP, Vaz MMOLL, et al., 2013. Evaluation of a propolis water extract using a reliable RP-HPLC methodology and in vitro and in vivo efficacy and safety characterization. Evid Based Complement Alternat Med 2013: 1-11.
127. Roy N, Mondal S, Laskar RA, Basu S, Mandal D, Begum NA,. 2010. Biogenic synthesis of Au and Ag nanoparticles by Indian propolis and its constituents. Colloids Surf B Biointerfaces 76: 317-325.
128. Rudeschko O, Machnik A, Dorfelt H, Kaatz HH, Schlott B, Kinne RW,. 2004. A novel inhalation allergen present in the working environment of beekeepers. Allergy 59: 332-337.
129. Salatino A, Teixeira EW, Negri G, Message D,. 2005. Origin and chemical variation of Brazilian propolis. Evid Based Complement Alternat Med 2: 33-38.
130. Salomão K, Dantas AP, Borba CM, et al., 2004. Chemical composition and microbicidal activity of extracts from Brazilian and Bulgarian propolis. Lett Appl Microbiol 38: 87-92.
131. Santos VR, Gomes RT, de Mesquita RA, et al., 2008. Efficacy of Brazilian propolis gel for the management of denture stomatitis: a pilot study. Phytother Res 22: 1544-1547.
132. Sá-Nunes A, Faccioli LH, Sforcin JM,. 2003. Propolis: lymphocyte proliferation and IFN-gamma production. J Ethnopharmacol 87: 93-97.
133. Savka MA, Dailey L, Popova M, et al., 2015. Chemical composition and disruption of quorum sensing signaling in geographically diverse United States propolis. Evid Based Complement Alternat Med 2015: 1-10.
134. Scazzocchio F, D'auria FD, Alessandrini D, Pantanella F,. 2006. Multifactorial aspects of antimicrobial activity of propolis. Microbiol Res 161: 327-333.
135. Scheller S, Gazda G, Pietsz G, et al., 1988. The ability of ethanol extract of propolis to stimulate plaque formation in immunized mouse spleen cells. Pharmacol Res Commun 20: 323-328.
136. Serra Bonvehí J, Ventura CF,. 2000. Study on propolis quality from China and Uruguay. Z Naturforsch C 55: 778-784.
137. Sforcin JM,. 2007. Propolis and the immune system: a review. J Ethnopharmacol 113: 1-14.
138. Sforcin JM, Bankova V,. 2011. Propolis: is there a potential for the development of new drugs? J Ethnopharmacol 133: 253-260.
139. Sforcin JM, Funari SRC, Novelli ELB,. 1995. Serum biochemical determinations of propolis-treated rats. J Venom Anim Toxins 1: 31-37.
140. Sforcin JM, Fernandes A Jr, Lopes CAM, Bankova V, Funari SRC,. 2000. Seasonal effect on Brazilian propolis antibacterial activity. J Ethnopharmacol 73: 243-249.
141. Sforcin JM, Fernandes A Jr, Lopes CAM, Funari SRC, Bankova V,. 2001. Seasonal effect of Brazilian propolis on Candida albicans and Candida tropicalis. J Venom Anim Toxins 7: 139-144.
142. Sforcin JM, Kaneno R, Funari SRC,. 2002a. Absence of seasonal effect on the immunomodulatory action of Brazilian propolis on natural killer activity. J Venom Anim Toxins 8: 19-29.
143. Sforcin JM, Novelli ELB, Funari SRC,. 2002b. Seasonal effect of Brazilian propolis on seric biochemical variables. J Venom Anim Toxins 8: 244-254.
144. Sforcin JM, Orsi RO, Bankova V,. 2005. Effects of propolis, some isolated compounds and its source plant on antibody production. J Ethnopharmacol 98: 301-305.
145. Siheri W, Igoli JO, Gray AI, et al., 2014. The isolation of antiprotozoal compounds from Libyan propolis. Phytother Res 28: 1756-1760.
146. Silva SS, Thomé GS, Cataneo AHD, et al., 2013. Brazilian propolis antileishmanial and immunomodulatory effects. Evid Based Complement Alternat Med 2013: 1-7.
147. Silva SS, Mizokami SS, Fanti JR, et al., 2015. Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice. Parasitol Res. DOI: 10.1007/s00436-015-4890-4, in press.
148. Silva-Carvalho R, Baltazar F, Almeida-Aguiar C,. 2015. Propolis: a complex natural product with a plethora of biological activities that can be explored for drug development. Evid Based Complement Alternat Med 2015: 1-29.
149. Simões LMC, Gregório LE, Silva Filho AA, et al., 2004. Effect of Brazilian green propolis on the production of reactive oxygen species by stimulated neutrophils. J Ethnopharmacol 94: 59-65.
150. Simone M, Evans JD, Spivak M,. 2009. Resin collection and social immunity in honey bees. Evolution 63: 3016-3022.
151. Siqueira ABS, Rodrigues LRNA, Santos RKB, et al., 2015. Antifungal activity of propolis against Candida species isolated from cases of chronic periodontitis. Braz Oral Res 29: 1-6.
152. Su KY, Hsieh CY, Chen YW, Chuang CT, Chen CT, Chen YL,. 2014. Taiwanese green propolis and propolin G protect the liver from the pathogenesis of fibrosis via eliminating TGF-β-induced Smad2/3 phosphorylation. J Agric Food Chem 62: 3192-3201.
153. Suárez D, Zayas D, Guisado F,. 2005. Propolis: patents and technology trends for health applications. J Bus Chem 2: 119-125.
154. Szliszka E, Mertas A, Czuba ZP, Król W,. 2013. Inhibition of inflammatory response by artepillin C in activated RAW264.7 macrophages. Evid Based Complement Alternat Med 2013: 1-7.
155. Szweda P, Gucwa K, Kurzyk E, et al., 2015. Essential oils, silver nanoparticles and propolis as alternative agents against fluconazole resistant Candida albicans, Candida glabrata and Candida krusei clinical isolates. Indian J Microbiol 55: 175-183.
156. Takaisi-Kikuni NB, Schilcher H,. 1994. Electron microscopic and microcalorimetric investigations of the possible mechanism of the antibacterial action of a defined propolis provenance. Planta Med 60: 222-227.
157. Tanaka M, Okamoto Y, Fukui T, Masuzawa T,. 2012. Suppression of interleukin 17 production by Brazilian propolis in mice with collagen-induced arthritis. Inflammopharmacology 20: 19-26.
158. Tavares DC, Mazzaron Barcelos GR, Silva LF, Chacon Tonin CC, Bastos JK,. 2006. Propolis-induced genotoxicity and antigenotoxicity in Chinese hamster ovary cells. Toxicol In Vitro 20: 1154-1158.
159. Tavares DC, Lira WM, Santini CB, Takahashi CS, Bastos JK,. 2007. Effects of propolis crude hydroalcoholic extract on chromosomal aberrations induced by doxorubicin in rats. Planta Med 73: 1531-1536.
160. Toreti VC, Sato HH, Pastore GM, Park YK,. 2013. Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid Based Complement Alternat Med 2013: 1-13.
161. Trusheva B, Trunkova D, Bankova V,. 2007. Different extraction methods of biologically active components from propolis: a preliminary study. Chem Cent J 1: 13.
162. Trusheva B, Popova M, Koendhori EB, Tsvetkova I, Naydenski C, Bankova V,. 2011. Indonesian propolis: chemical composition, biological activity and botanical origin. Nat Prod Res 25: 606-613.
163. Velikova M, Bankova V, Sorkun K, Houcine S, Tsvetkova I, Kujumgiev A,. 2000. Propolis from the Mediterranean region: chemical composition and antimicrobial activity. Z Naturforsch C 55: 790-793.
164. Veloz JJ, Saavedra N, Lillo A, Alvear M, Barrientos L, Salazar LA,. 2015. Antibiofilm activity of Chilean propolis on Streptococcus mutans is influenced by the year of collection. BioMed Res Int 2015: 1-6.
165. Vynograd N, Vynograd I, Sosnowski Z,. 2000. A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV). Phytomedicine 7: 1-6.
166. Wang K, Ping S, Huang S, et al., 2013. Molecular mechanisms underlying the in vitro anti-inflammatory effects of a flavonoid-rich ethanol extract from Chinese propolis (poplar type). Evid Based Complement Alternat Med 2013: 1-11.
167. Washio K, Kobayashi M, Saito N, Amagasa M, Kitamura H,. 2015. Propolis ethanol extract stimulates cytokine and chemokine production through NF-κB Activation in C2C12 myoblasts. Evid Based Complement Alternat Med 2015: 1-7.
168. Watanabe MAE, Amarante MK, Conti BJ, Sforcin JM,. 2011. Cytotoxic constituents of propolis inducing anticancer effects: a review. J Pharm Pharmacol 63: 1378-1386.
169. Yang Y, Wei K, Yang S, et al., 2015. Co-adjuvant effects of plant polysaccharide and propolis on chickens inoculated with Bordetella avium inactivated vaccine. Avian Pathol 44: 248-253.